Eli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk. - Barron's
July 31, 2025 Barron's

Eli Lilly Weight-Loss Drug Makes Cardio Advance. More Bad News for Novo Nordisk. - Barron's

Eli Lillysbest-selling drug Mounjaro has shown cardiovascular advantages in diabetes patients, the company said early Thursday, in a sign it might be edging closer to getting the benefit included on …